Cover Image
市場調查報告書

腦膜炎疫苗:流行病學、病患人數的市場預測,治療流程,已上市/開發平台藥物分析

Meningococcal vaccines: Epidemiology and patient-based market forecasts, treatment algorithm, and marketed and pipeline drug analysis

出版商 Datamonitor Healthcare 商品編碼 365206
出版日期 內容資訊 英文 161 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
腦膜炎疫苗:流行病學、病患人數的市場預測,治療流程,已上市/開發平台藥物分析 Meningococcal vaccines: Epidemiology and patient-based market forecasts, treatment algorithm, and marketed and pipeline drug analysis
出版日期: 2016年06月01日 內容資訊: 英文 161 Pages
簡介

美國、義大利、英國在近幾年中,高價格的腦膜炎B (MenB) 疫苗受認證,將開始定期接種,那使得腦膜炎疫苗市場成長。預期還有GlaxoSmithKline所開發的MenABCW-135Y疫苗2021年將上市,使這個市場進一步成長。

本報告提供已上市/臨床實驗中 (開發平台上)的腦膜炎疫苗相關分析,各產品的市場規模的估計值,各國市場的主要產品的排行榜,及今後的疫苗接種率預測,各國內部最有潛力的風險族群,開發中產品的各國的認證預測及障礙等相關調查。

市場預測:腦膜炎疫苗

  • 摘要整理
  • 市場概要與趨勢
  • 市場定義
  • 美國市場的預測
  • 法國市場預測
  • 德國市場預測
  • 義大利市場預測
  • 西班牙市場預測
  • 英國市場預測
  • 主要的意見領袖分析

已上市藥物:腦膜炎疫苗

  • 摘要整理
  • 產品概要
  • 產品簡介:Bexsero
  • 產品簡介:Menactra
  • 產品簡介:Menveo
  • 產品簡介:Trumenba

開發中產品:肺炎球菌疫苗

  • 摘要整理
  • 臨床實驗開發平台概要
  • 產品簡介 (最後階段):Men Quad TT
  • 產品簡介 (最後階段):MenABCW-135Y

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DMKC10644

The recent inclusion of premium-priced meningococcal B (MenB) vaccines into the routine immunization schedules of the US, Italy, and the UK is set to drive strong market growth, which will be further boosted by the anticipated launch of GlaxoSmithKline's pentavalent MenABCW-135Y vaccine from 2021.

This report addresses the following questions:

  • Which vaccine classes are forecast to be the most successful in each of the US and five major EU markets (France, Germany, Italy, Spain, and the UK)?
  • How will vaccination rates for meningococcal disease change over the forecast period?
  • Which risk groups are the most lucrative in each of the US and five major EU markets?
  • Why have France, Germany, and Spain refused to recommend routine MenB vaccination, and how should GlaxoSmithKline address payer concerns?
  • How will the launch of MenABCW-135Yimpact the use of standalone meningococcal ACWY (MenACWY) and MenB vaccines?

TABLE OF CONTENTS

FORECAST: MENINGOCOCCAL VACCINES

  • 1. Executive Summary
  • 2. Market Overview and Trends
  • 3. Market Definition
  • 4. US Market Forecast
  • 5. France Market Forecast
  • 6. Germany Market Forecast
  • 7. Italy Market Forecast
  • 8. Spain Market Forecast
  • 9. UK Market Forecast
  • 10. Key Opinion Leader Research

MARKETED DRUGS: MENINGOCOCCAL VACCINES

  • 11. Executive Summary
  • 12. Product Overview
  • 13. Product profile: Bexsero
  • 14. Product profile: Menactra
  • 15. Product profile: Menveo
  • 16. Product profile: Trumenba

PIPELINE: MENINGOCOCCAL VACCINES

  • 17. Executive Summary
  • 18. Clinical Pipeline Overview
  • 19. Product profile (late stage): Men Quad TT
  • 20. Product profile (late stage): MenABCW-135Y
Back to Top